GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Enovis Corp (LTS:0I1B) » Definitions » Loans Receivable

Enovis (LTS:0I1B) Loans Receivable : $0 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Enovis Loans Receivable?

Enovis's Loans Receivable for the quarter that ended in Mar. 2024 was $0 Mil.


Enovis Loans Receivable Historical Data

The historical data trend for Enovis's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enovis Loans Receivable Chart

Enovis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Enovis Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Enovis Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Enovis Loans Receivable Related Terms

Thank you for viewing the detailed overview of Enovis's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Enovis (LTS:0I1B) Business Description

Traded in Other Exchanges
Address
2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy.. The company conducts its operations through two operating segments: Prevention & Recovery ("P&R") and Reconstructive ("Recon"). It generates majority revenue form Prevention & Recovery segment.

Enovis (LTS:0I1B) Headlines

No Headlines